Compare Deckers Outdoor Corp (DECK) vs Stryker Corporation (SYK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deckers Outdoor Corp vs Stryker Corporation — how do they compare? Deckers Outdoor Corp trades at $83 (market cap $11.24B), while Stryker Corporation trades at $277.34 (market cap $106.24B). The key difference: Stryker Corporation is far larger — about 9.5× Deckers Outdoor Corp's market cap, and Stryker Corporation pays a 1.27% dividend while Deckers Outdoor Corp pays none. Which is the better fit depends on your goals — on Pluang, investors hold Deckers Outdoor Corp for 71 Days and Stryker Corporation for 21 Days on average.
| DECK | SYK | |
|---|---|---|
Market Cap | $11.24B | $106.24B |
Volume | 3,010,945 | 2,982,001 |
Sector | Consumer Cyclical | Health |
52-Week High | $120.94 | $388.35 |
52-Week Low | $77.51 | $269.75 |
Typical Hold Time | 71 Days | 21 Days |
Enterprise Value | $10.11B | $117.70B |
Dividend Yield | — | 1.27% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deckers Outdoor (DECK) trades at $83.32, up 3.66% with strong momentum as technical indicators show bullish signals. The company demonstrates robust fundamentals with revenue growing from $3.2B in 2022 to $5.0B in 2025, net profit margin expanding to 19.37%, and attractive valuation metrics including P/E of 11.74. Recent earnings beats and strong HOKA/UGG brand performance support positive sentiment.
Outlook remains positive with 44.65% analyst buy ratings and $117.13 consensus price target suggesting 40% upside potential. Key risks include competitive pressures in footwear sector and potential consumer spending slowdown. The stock presents a compelling growth opportunity with strong cash flow generation and expanding margins.
Stryker (SYK) trades at $277.52, up 0.77% today, amid a mixed technical and fundamental backdrop. The stock shows a bearish technical signal with key support at $274 and resistance at $279. Fundamentally, the company reported strong profitability with a 14.43% net income margin in 2026 and beat EPS estimates in two of the last three quarters. However, recent news highlights potential legal and manufacturing issues that have pressured investor sentiment.
The outlook is cautiously optimistic, with a consensus price target of $368.11 implying significant upside. Investment opportunities lie in SYK's robust earnings growth and market leadership in medical technology, but risks include ongoing legal investigations and persistent manufacturing challenges that could impact future performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deckers Outdoor Corp
Deckers Outdoor Corp designs and sells casual and performance footwear, apparel, and accessories. Primary brands include UGG, Teva, and Sanuk. The company distributes Most of its products through its wholesale business, but it also has a substantial direct-to-consumer business with its company-owned retail stores and websites. Most sales are in the United States, although the company also has retail stores and distributors throughout Europe, Asia, Canada, and Latin America. Deckers sources its products from independent manufacturers primarily in Asia.
Read more on DECK →About Stryker Corporation
Stryker is a global leader in medical technology, specializing in Orthopaedics, MedSurg, and Neurotechnology. It is renowned for its highly decentralized business model, which empowers 22 specialized business units to drive innovation and category leadership. With its market-leading Mako SmartRobotics™ platform and a relentless M&A strategy, Stryker provides a comprehensive ecosystem of connected surgical tools, implants, and digital solutions that improve both clinical and financial outcomes for hospitals worldwide.
Read more on SYK →
